α-Synuclein (AS) aggregation is associated to neurodegeneration in Parkinson's disease (PD). At the same time, alterations in metal ion homeostasis may play a pivotal role in the progression of AS amyloid assembly and the onset of PD. Elucidation of the structural basis directing AS-metal interactions and their effect on AS aggregation constitutes a key step towards understanding the role of metal ions in AS amyloid formation and neurodegeneration. Despite of the reported evidences that link Zn 2+ with the pathophysiology of PD and the fact that this metal ion was shown to promote AS fibrillation in vitro, neither the structural characterization of the binding sites nor the identification of the amino acids involved in the interaction of Zn 2+ with the protein AS has been carried out. By using NMR spectroscopy, we have addressed here unknown structural details related to the binding of Zn 2+ to the protein AS through the design of site-directed and domain truncated mutants of AS. The binding of zinc to the Aβ peptide was also studied and discussed comparatively. Although the results of this study contribute to the understanding of the structural and molecular basis behind the acceleration of AS fibrillation mediated by Zn 2+ , the low affinity that characterizes the interaction of Zn 2+ with AS contrasts strongly with the high-affinity features reported for the binding of this metal ion to other target proteins linked to human amylodosis such as Aβ peptide and the Islet Amyloid Polypeptide (IAPP), challenging the biological relevance of zinc interactions in the pathogenesis of PD.
Introduction
The misfolding of proteins into a toxic conformation is proposed to be at the molecular foundation of a number of neurodegenerative disorders including Creutzfeldt-Jacob's disease, Alzheimer's (AD) and Parkinson's disease (PD) [1] . One common and defining feature of protein misfolding diseases is the formation and deposition of protein aggregates in various morphologies, including amyloid fibrils [2] . Neurodegeneration in PD is progressive and is characterized by the loss of dopaminergic neurons in the substantia nigra, and the presence of amyloid fibrillar aggregates in multiple brain regions containing the protein α-synuclein (AS) [3] [4] [5] [6] . α-Synuclein is a highly soluble, intrinsically disordered protein, predominantly expressed in the neurons of the central nervous system and localized at presynaptic terminals in close proximity to synaptic vesicles [7] [8] [9] . Evidence that AS amyloidogenesis plays a causative role in the development of PD is furnished by a variety of genetic, neuropathological and biochemical studies [4, 5, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
α-Synuclein comprises 140 amino acid residues distributed in three different regions: the N-terminal region, which encompasses residues 1-60, includes the imperfect repeats KTKEGV and is involved in lipid binding [20] [21] [22] ; the highly hydrophobic self-aggregating sequence known as NAC (non-amyloid-β component, residues , which initiates fibrillation [23] ; and the acidic C-terminal region, rich in Pro, Asp and Glu amino acids, which encompasses residues 96-140 and is essential for blocking rapid AS filament assembly [24] [25] [26] . In its monomeric, intrinsically disordered state, the protein is best described as an ensemble of structurally heterogeneous conformations, with no persistent secondary structure and with long-range inter-residue interactions that have been shown to stabilize aggregation-autoinhibited conformations [27] [28] [29] [30] . These intramolecular contacts in AS are mainly established between the C-terminus and the NAC regions (hydrophobic interactions), and between the C-and N-terminal regions (electrostatic interactions) [27] [28] [29] .
Although it remains unclear how AS can initiate neuronal death, it is certain that the amyloid aggregation of AS is essential for the pathological effects associated to PD. Even if amyloid assembly is a complex and multifaceted process, the dominant risk factor associated with PD and other neurodegenerative diseases is increasing age.
Several studies indicate that one of the consequences of normal aging is a rise in the levels of metal ions in brain tissue [31, 32] . The brain is an organ that concentrates metal ions, and there is now increasing evidence that a perturbation in metal homeostasis may be a key factor in a variety of age-related neurodegenerative diseases. This data support the hypothesis that metal interactions with the target protein in several of these age-dependent degenerative diseases might constitute one of the major factors contributing to their etiology. Accordingly, copper and manganese have been implicated in Creutzfeldt-Jakob's disease [33] [34] [35] [36] , whereas several studies emphasize the role of copper and zinc as contributors to the neuropathology of AD [34, [37] [38] [39] [40] . Furthermore, coordination environments for copper complexes in the prion protein, and copper and zinc in the Aβ peptide have been very well characterized by several biophysical and structural studies [35] [36] [37] .
The role of metal ions in AS amyloid assembly and neurodegeneration is also becoming a central question in the pathophysiology of PD [62] . Iron deposits were identified in Lewy bodies [63] and elevated copper concentrations were found in the cerebrospinal fluid of PD patients [64] . Analysis of the parkinsonian substantia nigra revealed also enhanced levels of zinc in comparison with the control tissues [62, [65] [66] [67] [68] . Furthermore, epidemiological research indicates that individuals with chronic exposure to copper, manganese, zinc or iron display an increased rate of PD [69] . A comparative analysis between the structural and affinity features of AS complexed to the biologically relevant divalent metal ions copper, iron and manganese demonstrated conclusively a hierarchal effect of AS-metal interactions on AS aggregation kinetics, dictated largely by structural factors corresponding to different protein regions [70, 71] . While Fe 2+ and Mn 2+ interact at a non-specific, low-affinity binding interface at the C-terminus of AS, Cu 2+ binds with high affinity at the N-terminal region and it was the most effective metal ion in accelerating AS filament assembly [70, 71] . Interestingly, despite of the reported evidences that link Zn
2+
with the pathophysiology of PD and the fact that this metal ion was shown to promote AS fibrillation in vitro [67, 68, [72] [73] [74] [75] , neither the structural characterization of the binding sites nor the identification of the amino acids involved in the interaction of Zn 2+ with the protein AS have been carried out. Accordingly, in this work we sought to delineate the structural basis behind the interaction of Zn 2+ with AS, as a first step towards the understanding of the molecular mechanism by which Zn 2+ accelerates AS filament assembly. The identity of the Zn 2+ binding ligands and the affinity features of the metal binding sites were elucidated through the design of site-directed and domain-truncated mutants of AS and application of NMR spectroscopy ( Fig. 1 ). These new findings of the bioinorganic chemistry of PD are discussed via a comparative analysis with the Zn 2+ binding
Aβ peptide of AD.
Experimental section

Proteins and reagents
The proteins AS, H50A AS and 1-108 AS were prepared as previously described [25, 26] . The H50A mutant was constructed using the Quick-Change site-directed mutagenesis kit (Stratagene) on AS sequence-containing plasmids. The introduced modification was further verified by DNA sequencing. Purified proteins were dialyzed against Buffer A (20 mM MES (2-(N-morpholino)ethanesulfonic acid), 20 mM MOPS (3-(N-morpholino)propanesulfonic acid), 100 mM NaCl, pH range 5.0-7.5), all treated with Chelex (Sigma). ZnSO 4 salt of the highest purity available was purchased from Merck. Deuterium oxide was purchased from Sigma. Non-labeled and 15 N isotopically enriched Aβ(1-40) samples were purchased from EZBiolab and Alexotech, respectively. Peptides were dissolved in 10 mM NaOH solutions and stored at − 80°C. Prior to performing the NMR experiments, Aβ samples were dissolved in Buffer B (20 mM TRIS, pH 7.5) and centrifuged at 20,000 g to eliminate potentially pre-formed aggregates [76] .
NMR spectroscopy
NMR spectra were acquired on a Bruker Avance II 600 MHz spectrometer using a triple-resonance probe equipped with z-axis self-shielded gradient coils. Heteronuclear Single Quantum Coherence (HSQC) spectra were registered at 15°C on 100 μM Residual dipolar couplings (RDCs) were measured on 15 N-AS samples aligned in 5% (w/v) n-octyl-penta(ethylene glycol)/octanol (C8E5) [77] . Formation of the anisotropic, dilute liquid crystalline phase was monitored by the splitting of the deuterium signal and ranged on 20 ± 2 Hz. One-bond N-H residual dipolar couplings (D NH ) were acquired using the 2D inphase-antiphase (IPAP)-HSQC sequence under both isotropic and anisotropic conditions [78] .
For metal ion [71, [80] [81] [82] [83] . The I/I 0 ratios of non-overlapping cross-peaks were plotted as a function of the protein sequence to obtain the intensity profiles. classes of independent, non-interactive binding sites per protein molecule (with apparent dissociation constants K d1 and K d2 ). The program DynaFit was used in the affinity analysis [84] . Acquisition, processing and visualization of the NMR spectra were performed by using TOPSPIN 2.0 (Bruker) and Sparky (Goddard and Kelner, UCSF).
Results
NMR mapping of the AS-Zn 2+ complexes
The details of Zn 2+ binding to the protein AS were explored at a single-residue resolution level by using NMR spectroscopy. N HSQC spectra retained the excellent resolution of the uncomplexed protein but demonstrated significant backbone chemical shift changes in a discrete number of residues located at the N-and C-terminal regions of the protein ( Fig. 2A ). The strongest effects at 100 μM Zn 2+ were centered on the amide group of Asp121 in the C-terminal region, whereas at higher levels of the added metal ion (~300 μM) a clear effect became evident at the N-terminal region centered on the amide group of His50 ( Fig. 2A) . The changes at the C-terminus were further pronounced and generalized at higher levels of Zn 2+ (~500 μM), likely reflecting the transient population of secondary sites at the C-terminus ( Fig. 2A) (Fig. 4A-B) . Altogether, these data demonstrate conclusively that the transient long range interactions in AS do not influence the binding preferences of Zn 2+ at each site. 
Zn 2+ binding to AS is a low affinity process
To assess the affinity features of the AS-Zn 2+ interaction, the disso- [85] , whereas increments up to 50% of these levels were reported in the substantia nigra of PD patients [62, 65, 66] . Comparatively, Zn 2+ levels in the mM range have been reported in amyloid plaques of AD patients [86] . Thus, the low affinity features characterizing the binding of Zn 2+ to AS challenge the biological relevance of AS-Zn 2+ interactions in the pathogenesis of PD.
Structural determinants of Zn 2+ binding to AS
As previously reported, residual dipolar couplings (RDC) constitute an excellent tool to characterize the slow-dynamics of AS in its monomeric state [27, 87] . The RDC profile of AS is characterized by predominantly positive couplings that become exceptionally large for residues 115-119 and 125-129 in the C-terminus, indicative of a higher degree of restricted motions in that region (Fig. 6A) . Interestingly, the residues being affected primarily in the C-terminus by the lower concentrations of added zinc were Asp121, Asn122 and Glu123, which are contained in the linker sequence showing couplings close to zero and connecting the two major peaks of the RDC profile (115-119 and 125-129) (Fig. 6B) . The strong correlation between the location of the primary Zn 2+ binding site in the C-terminus and the dynamic and structural properties inherent to that region suggests that the presence of a specific spatial organization about residues 121-123 might result in a particular orientation of the coordination moieties favoring metal binding to this region [71] . Indeed, despite the presence of a cluster of negatively charged residues around Asp135, comprising Glu130, Glu131, Glu137, and Glu139, a noticeable difference was observed in the metal binding capabilities of the regions centered on Asp121 and Asp135. Consistent with the binding of other divalent metal ions to the C-terminal region, we can conclude that the binding of Zn 2+ ions to the C-terminus of AS is not driven exclusively by electrostatic interactions but mostly modulated by the intrinsic conformation of that region [71] . Interestingly, no substantial changes were observed in the RDC profile of AS in the presence of mM levels of Zn
2+
, revealing that the dynamic and structural features of the protein are not severely affected upon metal-complex formation (data not shown).
The results presented in this section provided compelling evidence for a common low-affinity metal binding interface at the C-terminus, whose structural and dynamic properties determine the preferences of binding of divalent metal ions to that region. On the other hand, the low-affinity binding of Zn 2+ to the N-terminal region is related to the presence of a single histidine located in an unstructured region of the protein, being mostly determined by the efficient role played by imidazole side-chains as metal-chelating anchoring groups [88, 89] .
Structural features of Aβ-Zn 2+ complexes
The structural features of Zn 2+ binding to Aβ peptide were also explored by measuring the 1 H-15 N HSQC spectra of Aβ(1-40) peptide (Aβ40) in the absence and presence of increasing concentrations of Zn 2+ (Fig. 7) . The tendency of the Aβ40 peptide to aggregate is higher than AS and, thus, all the measurements were conducted at the low temperature of 5°C and peptide concentration of 100 μM, where the sample remains stable. As previously reported, the spectral changes observed upon Zn 2+ addition were centered on residues His6, His13 and His14, clearly indicating the involvement of the imidazole ring of these residues as metal coordinating moieties (Fig. 7) . In contrast to the binding behavior observed for the AS-Zn 2+ complexes, the affected Aβ40 resonances were severely broadened by the addition of substoichiometric concentrations of zinc (0.2-0.5 equivalents) (Fig. 7A ). Further addition of Zn 2+ caused the Glu3, Phe4, Arg5, Asp7, Glu11, Val12, His13, Gln15, Lys16 signals to be broadened beyond detection (Fig. 7B) caused the His6,13,14 and Tyr10 signals to be broadened beyond detection (Fig. 8D) , once more indicative of a system undergoing intermediate exchange on the NMR chemical shift timescale. Altogether, the 1D and 2D NMR titration experiments showed that the degree of broadening induced by Zn 2+ ions on the aromatic side chains of Aβ40 decrease in the order His6,13,14 > Phe4,Tyr10 ≫ Phe19,Phe20, confirming that histidines at positions 6, 13 and 14 constitute the main anchoring residues for Zn 2+ binding to Aβ40. H ΔCS values of the imidazolic proton Hε of His50 were used in D. Curves represent the fit to the models described in the text, by using the program DynaFit.
Discussion
Metal ions, especially copper, zinc and iron are considered as risk factors for AD and PD based on clinical and epidemiological studies [31, 32] . The simplest mechanism proposed involves a direct effect of the metal ions on the aggregation of the target proteins linked to these diseases. The effects reported for Zn 2+ ions on AS fibrillation revealed that metal concentrations in the mM range, far greater than those normally occurring in tissues, are necessary to accelerate the amyloid aggregation of the protein [67, 68, [72] [73] [74] [75] , which argue against the physiological relevance that these effects might have on the etiology of the disease. Furthermore, no structural characterization of the Zn 2+ binding sites, or the identification of the amino acids involved in the metal-AS interactions has been reported to date. The lack of structural and affinity data supporting the reported effects of Zn 2+ on AS aggregation in vitro was the driving force that prompted us to address these unresolved details related to the binding of Zn 2+ ions to AS. In this work we sought to characterize structurally the interaction of Zn , Co 2+ and Ni 2+ ions [71] .
Altogether, the data prove conclusively that the binding of Zn 2+ to the C-terminus of AS takes place primarily in a well-defined region, likely involving Asp121 as the main anchoring residue, and that the protein AS binds metals to the C-terminus with very low selectivity. Interestingly, as observed for Cu 2+ ions, a Zn 2+ binding site was also identified in the unstructured N-terminal region around the sole His50 residue. Our study demonstrated conclusively that the imidazol ring of the histidine residue is the anchoring group for zinc binding to the N-terminal region of AS. However, the affinity features reported for the AS-metal complexes at this site varies from 35 μM in the case of Cu 2+ ions [81] to around 1 mM for Zn 2+ ions. Contrasting with the lack of selectivity that characterizes the binding of metal ions to the C-terminus, a hierarchy seems to exist for AS-metal interactions at the His50 site, likely determined by the nature of the metal ion involved and its coordination geometry preferences. Indeed, Cu 2+ is known to promote ionization of amide groups of peptides if a histidine residue is available as a primary binding site, forming preferentially an intramolecular His(N π )/amide(N − )-Cu 2+ chelation environment [90] , as has been reported recently for the AS-Cu 2+ complex formed at the His site [91] .
In contrast, zinc prefers to bind four to six ligands, promoting intermolecular His(N)-Zn
2+
-His(N) metal-bridged complexes [61, 92, 93] . However, the NMR structural characterization and the dissociation constant reported here for the His50-Zn 2+ complex argue against the formation of an intermolecular zinc-bridged complex. Indeed, as will be [94] . Individually, the imidazole of a single histidine has a dissociation constant for zinc in the low millimolar range [95, 96] , which is similar to that revealed here for the His50-Zn 2+ complex but that is significantly higher than the low micromolar binding (K d~1 -15 μM) reported by several studies for the Aβ-Zn 2+ complex [40, 58, 59, 97, 98] . Thus, the presence of a zinc coordinating motif formed by histidine residues located at different locations of the Aβ sequence, compared with the sole His50 in AS, seems to be the key difference that influences the structural and affinity features for Zn 2+ in these proteins. Indeed, a minimum of three histidines is also required to obtain the low micromolar affinity complex formed between Zn 2+ and the islet amyloid polypeptide (IAPP), related to type II diabetes [92] . The IAPP molecule contains only one residue (His18) that binds zinc tightly (K d~1 μM), resulting from the coordination of six IAPP molecules with a single zinc [92, 99] . Intermolecular binding modes are also promoted by Zn 2+ binding to Aβ, giving rise to a network of Aβ peptides that are cross-linked by a Zn 2+ bridge binding histidines belonging to adjacent peptides [40, 100, 101] . Whereas the relatively unstructured nature of IAPP and Aβ peptides may facilitate additional metal-bound ligands [102, 103] , the existence of transient long-range interactions and the partial lack of conformational flexibility of AS might be the main structural factors disfavoring the formation of zinc-bridged, intermolecular complexes. In addition to demonstrating the existence of important structural differences between the AS-Zn 2+ and Aβ-Zn 2+ coordination modes, our study may contribute to understand the molecular origin of the impact that these interactions exert on the amyloid fibril formation of these proteins. Indeed, whereas the formation of high-affinity, intermolecular Zn 2+ complexes in Aβ prevents amyloid fibril formation, likely by stabilizing non-fibrillar species or inducing extensive amyloid polymorphism [101, 104, 105] , the low-affinity binding of Zn 2+ ions to AS results in the formation of intramolecular AS-Zn 2+ complexes and acceleration of the amyloid fibril formation of the protein. Overall, a coordination site formed mostly by carboxylate moieties or a single imidazol ring is in agreement with the modest affinity constants observed for Zn 2+ binding to AS, and thus the high levels of this metal ion required to induce the aggregation of AS [75] . Regarding the molecular mechanism behind Zn 2+ induced acceleration of AS fibrillation, it was proposed to be mediated exclusively by the binding of the metal ion to the negatively charged carboxylates in the C-terminal region, leading to masking of the electrostatic repulsion and the collapse to a partially-folded conformation [106, 107] . As might be noted, this hypothesis does not consider His50 as a residue playing an active role in the Zn 2+ -mediated acceleration of AS fibrillation. Overall, our previous structural studies in the field of the bioinorganic chemistry of PD and the NMR evidences shown here argue against the presence of significant conformational changes in AS induced by the interaction with Zn 2+ , either the induction of a partially folded intermediate or even the formation of substantial amounts of intermolecular zinc-bridged AS species at the early stages of the aggregation process.
Although the results of this study begin to reveal the structural and molecular basis by which zinc accelerates AS amyloid fibril formation, more studies are needed to explore other biological aspects of AS-Zn 2+ interactions. However, the low affinity that characterizes the interaction of Zn 2+ with AS contrasts strongly with the high-affinity features reported for the binding of this metal ion to other target proteins linked to human amylodosis such as Aβ peptide and IAPP [58, 91, 98] , challenging the biological relevance of zinc interactions in the pathogenesis of PD.
